Peer Review reports
From: EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells
| Original Submission | ||
|---|---|---|
| 14 Jul 2020 | Submitted | Original manuscript |
| 10 Aug 2020 | Reviewed | Reviewer Report |
| 13 Aug 2020 | Reviewed | Reviewer Report |
| 13 Oct 2020 | Author responded | Author comments - Hao Gong |
| Resubmission - Version 2 | ||
| 13 Oct 2020 | Submitted | Manuscript version 2 |
| 21 Oct 2020 | Reviewed | Reviewer Report |
| 4 Nov 2020 | Reviewed | Reviewer Report |
| 8 Nov 2020 | Author responded | Author comments - Hao Gong |
| Resubmission - Version 3 | ||
| 8 Nov 2020 | Submitted | Manuscript version 3 |
| Publishing | ||
| 20 Nov 2020 | Editorially accepted | |
| 4 Dec 2020 | Article published | 10.1186/s12885-020-07667-7 |
You can find further information about peer review here.